| 000 | 01703 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513151229.0 | ||
| 264 | 0 | _c19981022 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0895-7061 | ||
| 024 | 7 |
_a10.1016/s0895-7061(98)00087-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeir, M R | |
| 245 | 0 | 0 |
_aNocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. _h[electronic resource] |
| 260 |
_bAmerican journal of hypertension _cAug 1998 |
||
| 300 |
_a914-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBlood Pressure Monitoring, Ambulatory |
| 650 | 0 | 4 | _aDiuretics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xtherapeutic use |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aLisinopril _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xtherapeutic use |
| 700 | 1 | _aReisin, E | |
| 700 | 1 | _aFalkner, B | |
| 700 | 1 | _aHutchinson, H G | |
| 700 | 1 | _aSha, L | |
| 700 | 1 | _aTuck, M L | |
| 773 | 0 |
_tAmerican journal of hypertension _gvol. 11 _gno. 8 Pt 1 _gp. 914-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0895-7061(98)00087-9 _zAvailable from publisher's website |
| 999 |
_c9681282 _d9681282 |
||